Thu Hoang is an associate in the Washington, D.C., office of Wilson Sonsini Goodrich & Rosati, where she is a member of the firm's antitrust practice.

  • J.D., The George Washington University Law School, 2015
  • LL.B., The Dickson Poon School of Law, King's College London, 2013
  • Co-author with S. Silber, J. Bank, and N. Mendelsohn, "Pharmaceutical Antitrust Legislation To Watch," Law360, May 28, 2019
  • Co-author with S. Creighton, J. Ferris, and R. Maddock, "Innovations Market Analysis: Twenty Years On" chapter, Douglas H. Ginsburg: An Antitrust Professor on the Bench, Vol. 1, Institute of Competition Law, 2018
  • "Competition in Prescription Drug Markets—A Summary of the November 8, 2017 FTC Workshop," Antitrust Health Care Chronicle, American Bar Association, February 2018
  • "U.S.A." chapter, Competition Litigation 2018, Tenth Edition, International Comparative Legal Guide, September 4, 2017
  • Co-author with S. Sher and C. Williams, "Narrowing the Investment-Only Exemption: An Examination of ValueAct and Where to Go from Here," The Exchange: Insurance and Financial Services Developments, Section of Antitrust Law, American Bar Association, Fall 2016
  • Co-author with J. Jacobson, "USA" chapter, "Competition Litigation 2016," The Strategic View, Global Legal Group, June 2016
  • "The EUMR White Paper: Reassessment of the Targeted Transparency System," International Antitrust Bulletin, ABA Section of Antitrust Law, Vol. 4, No. 1, 2014
  • Moderator, "No Crystal Ball Needed: Fundamentals of Antitrust Econometrics," American Bar Association, Section of Antitrust Law, Teleconference, May 20, 2019
  • Bar of the District of Columbia
  • State Bar of Maryland